Gilead Anti-Hep-C Treatment on the FDA Fast Track

Gilead Sciences  (NASDAQ: GILD  ) has received FDA priority review status for its New Drug Application for sofosbuvir, the company announced Friday.

Sofosbuvir is a once-daily oral nucleotide analogue inhibitor for the treatment of chronic hepatitis C virus (HCV) infection. Nucleotide analogue inhibitors are antiviral drugs that bind to reverse transcriptase, preventing RNA conversion to DNA.

Hepatitus C is a closely related family of viral liver diseases composed of several subtypes (genotypes). According to the Centers for Disease Control, most patients infected with HCV develop chronic infections. Most of these develop some degree of chronic liver disease. Fewer than 20% of people with chronic HCV will develop cirrhosis of the liver. Fewer than 5% will end up dying of cirrhosis or liver cancer caused by the virus.

The FDA grants priority review status to drug candidates that may offer major advancements in treatment over existing options. The FDA has set a target review date of Dec. 8 under the Prescription Drug User Fee Act.

Gilead proposes the use of sofosbuvir and ribavirin, or RBV, as an all-oral therapy for genotype 2 and 3 HCV infection, and the use of sofosbuvir with RBV and pegylated interferon for patients who have never been treated for genotype 1, 4, 5, or 6 infections in the past. 


Read/Post Comments (1) | Recommend This Article (8)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On June 08, 2013, at 9:54 PM, leonsote49 wrote:

    I few years back I was given eprivir ( medication for aids) for experiment at the VA hospital, becuase i had hep c&b, in 8 months my hep c was unditactable. In later years my emzyems were high so went to a liver specialist and he also gave eprivir, i told him i have taken it before and he was surprised, my emzyems went back to normal, this started 16 years ago. At the VA they said that i had hep c for over twenty years, since then i have been having cheked regularly and it has been OK know.

Add your comment.

DocumentId: 2479053, ~/Articles/ArticleHandler.aspx, 4/19/2014 6:29:16 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement